Article Text
Declarations of Interest
P26 How does the salford lung study in copd (sls copd) patient population fit into the gold 2017 classification grid?
Abstract
J Vestbo: Honoraria from GSK, AstraZeneca, BI, Chiesi, and Novartis for consulting/presenting
I Boucot: Employment and stock ownership (GSK)
L Frith: Employment and stock ownership (GSK)
N Diar Bakerly: Employing organisation provided IT support to automated data collection method for the SLS COPD trial. NDB received financial support to attend meeting in the form of non-restricting educational grants from GSK, Novartis, Astra Zeneca, and BI
S Collier: Employment and stock ownership (GSK)
DA Leather: Employment and stock ownership (GSK)
JM Gibson: Employing organisation provided IT support for automated data capture collected during SLS COPD
A Woodcock: Honoraria from GSK, Chiesi and Zambon